沙赫资本是诺瓦瓦克斯的主要股东之一，周五表示，在重组为家族办公室后，它不再寻求影响疫苗制造商的控制权。
该投资者已向美国证券交易委员会提交文件，自愿撤回其作为投资顾问的注册，它在监管文件中如此表示。
文件称，希曼苏·沙赫家族办公室有限责任公司已成立以管理投资。
Shah Capital, one of Novavax's top shareholders, said on Friday it no longer seeks to influence control of the vaccine maker after restructuring into a family office.
根据LSEG数据，希曼苏·沙赫是沙赫资本的创始人、总裁兼首席投资官，沙赫资本是诺瓦瓦克斯的第二大股东。
沙赫资本报告称其对诺瓦瓦克斯1054万股股份享有受益所有权，约占公司股份的6.39%。
文件还披露，沙赫资本基金有限责任公司于10月5日以平均每股约11.35美元的价格卖出287万股股份。
希曼苏·沙赫报告称其对诺瓦瓦克斯1066万股股份享有受益所有权，约占公司股份的6.46%。
The investor has filed with the US Securities and Exchange Commission to voluntarily withdraw its registration as an investment adviser, it said in a regulatory filing Himanshu Shah Family Office LLC has been established to manage the investments, the filing said Himanshu Shah is the founder, president and chief investment officer of Shah Capital, Novavax's second-largest shareholder, according to LSEG data Shah Capital reported beneficial ownership of 10.54 million Novavax shares, or about 6.39% of the company The filing also disclosed that Shah Capital Fund LLC sold 2.87 million shares on October 5 at an average price of about $11.35 apiece Himanshu Shah reported beneficial ownership of 10.66 million shares, representing about 6.46% of Novavax